Sort
16,300 grants matching “fatty liver disease”
SREBP-Mediated Regulation of Intestinal Epithelial Homeostasis
$422,820Luke James Engelking · Ut Southwestern Medical Center · R01 · FY2023 · DK
SREBP-Mediated Regulation of Intestinal Epithelial Homeostasis
$422,820Luke James Engelking · Ut Southwestern Medical Center · R01 · FY2021 · DK
SREBP-Mediated Regulation of Intestinal Epithelial Homeostasis
$422,820Luke James Engelking · Ut Southwestern Medical Center · R01 · FY2022 · DK
SREBP-Mediated Regulation of Intestinal Epithelial Homeostasis
$422,820Luke James Engelking · Ut Southwestern Medical Center · R01 · FY2019 · DK
SREBP-Mediated Regulation of Intestinal Epithelial Homeostasis
$422,820Luke James Engelking · Ut Southwestern Medical Center · R01 · FY2020 · DK
Novel regulatory mechanisms controlling hepatic apoB-Lp lipid loading and secretion
$422,764Edward A Fisher · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2025 · HL
DHA Reverses Gene Network Signatures of Fructose-induced Metabolic Syndrome
$422,722Xia Yang · University Of California Los Angeles · R01 · FY2015 · DK
Lipids, Inflammation and Insulin Action
$422,699Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2007 · DK
Base Excision DNA Repair in Premature Aging and Neurodegeneration
$422,697David Wilson · National Institute On Aging · ZIA · FY2012 · AG
Lipids, Inflammation and Insulin Action
$422,643Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2006 · DK
NUTRITION AND LIPOPROTEIN METABOLISM IN ATHEROSCLEROSIS
$422,597Wake Forest University Health Sciences · R01 · FY2001 · HL
Lipid Aldehyde and Ethanol Induced Liver Damage
$422,541Dennis Petersen · University Of Colorado Denver · R37 · FY2014 · AA
Role of microRNAs in lipid metabolism and cardiovascular disease
$422,500Carlos Fernandez Hernando · New York University School Of Medicine · R01 · FY2012 · HL
A mouse model of Dunnigan's Familial Partial Dystrophy
$422,500Constantine Londos · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Role of microRNAs in lipid metabolism and cardiovascular disease
$422,500Carlos Fernandez Hernando · New York University School Of Medicine · R01 · FY2011 · HL
Novel diagnostic and safety biomarkers of liver injury and hepatotoxicity
$422,483Stanislav I Svetlov · Banyan Biomarkers, Inc. · R44 · FY2008 · DK
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
$422,434Arun J Sanyal · Virginia Commonwealth University · U01 · FY2018 · DK
UT Gastroenterology/Hepatology Research Training Program
$422,140Ezra Burstein · Ut Southwestern Medical Center · T32 · FY2023 · DK
Signaling-pathway-based preventative strategies for alcoholic liver disease
$422,123Albert J Fornace · Georgetown University · R01 · FY2011 · AA
Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease
$422,101Irina A. Kirpich · University Of Louisville · R01 · FY2022 · AA
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C
$421,983Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Mechanisms underlying hepatic immune cell recruitment in nonalcoholic fatty liver disease
$421,886Reben Raeman · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Pathobiology of Liver Injury
$421,875Harmeet Malhi · Mayo Clinic Rochester · R01 · FY2023 · DK
Pathobiology of Liver Injury
$421,875Harmeet Malhi · Mayo Clinic Rochester · R01 · FY2025 · DK
MIF in progression and treatment of ALD
$421,823Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2016 · AA